Vistagen honored for outstanding workplace culture and mental health leadership

South san francisco, calif.--(business wire)--vistagen (nasdaq: vtgn), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, has earned two prestigious workplace honors in 2025, reinforcing its commitment to employee well-being and a strong, values-driven culture. for the third consecutive year, vistagen received mental health america's platinum bell sea.
VTGN Ratings Summary
VTGN Quant Ranking